ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,018.39
-0.34%
Dow Jones
37,903.29
0.23%
US Dollar vs MXN
16.9359
-0.05%
Brent Oil
84.035
0.59%
Bitcoin
57,771.09
-0.80%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Johnson and Johnson (JNJ)

  7. Johnson and Johnson (JNJ) Noticias

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:JNJ
FechaHoraFuenteTítuloSímboloCompañía
01/05/202405:30Business WireJohnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” ReorganizationNYSE:JNJJohnson and Johnson
22/04/202415:30Business WireJohnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)NYSE:JNJJohnson and Johnson
19/04/202406:31IH Market NewsParamount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and MoreNYSE:JNJJohnson and Johnson
17/04/202405:59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202415:33IH Market NewsU.S. Stocks Finish Lackluster Session Narrowly MixedNYSE:JNJJohnson and Johnson
16/04/202409:46Business WireCORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
16/04/202408:52IH Market NewsJ&J’s Q1 2024 sales rise 2.3% to $21.4 billionNYSE:JNJJohnson and Johnson
16/04/202408:09IH Market NewsDow Looks To Snap Six-Day Losing Streak As UnitedHealth SurgesNYSE:JNJJohnson and Johnson
16/04/202406:19IH Market NewsU.S. Index Futures Signal Mixed Trading, Oil Prices DipNYSE:JNJJohnson and Johnson
16/04/202406:18IH Market NewsEricsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More NewsNYSE:JNJJohnson and Johnson
16/04/202405:25Business WireJohnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%NYSE:JNJJohnson and Johnson
16/04/202405:20Business WireJohnson & Johnson Reports Q1 2024 ResultsNYSE:JNJJohnson and Johnson
15/04/202415:38IH Market NewsU.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales DataNYSE:JNJJohnson and Johnson
08/04/202417:06Business WireJohnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare ConferenceNYSE:JNJJohnson and Johnson
05/04/202422:21PR Newswire (US)CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of TherapyNYSE:JNJJohnson and Johnson
05/04/202413:55PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.NYSE:JNJJohnson and Johnson
05/04/202406:38IH Market NewsApple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More UpdatesNYSE:JNJJohnson and Johnson
05/04/202405:31Business WireJohnson & Johnson to Acquire Shockwave MedicalNYSE:JNJJohnson and Johnson
04/04/202417:01Business WireJohnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment CorporationNYSE:JNJJohnson and Johnson
02/04/202415:30Business WireJohnson & Johnson to Participate in the BofA Securities Health Care ConferenceNYSE:JNJJohnson and Johnson
28/03/202408:48IH Market NewsWalgreens Slashes Annual Profit Forecast; MillerKnoll Nosedives 17% on Bleak 4Q Outlook, and Latest NewsNYSE:JNJJohnson and Johnson
27/03/202405:54IH Market NewsGameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More NewsNYSE:JNJJohnson and Johnson
12/03/202408:15GlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNYSE:JNJJohnson and Johnson
11/03/202415:30Business WireJohnson & Johnson to Host Investor Conference Call on First-Quarter ResultsNYSE:JNJJohnson and Johnson
07/03/202415:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:JNJJohnson and Johnson
07/03/202407:33Business WireJohnson & Johnson Completes Acquisition of AmbrxNYSE:JNJJohnson and Johnson
01/03/202414:59PR Newswire (US)RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion MutationsNYSE:JNJJohnson and Johnson
20/02/202415:26PR Newswire (US)TECVAYLI® (teclistamab-cqyv) biweekly dosing approved by the U.S. FDA for the treatment of patients with relapsed or refractory multiple myelomaNYSE:JNJJohnson and Johnson
16/02/202415:12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:JNJJohnson and Johnson
16/02/202405:08IH Market NewsNike Workforce Reduction, The Trade Desk Soars 19% on $606 Million Revenue, and Latest NewsNYSE:JNJJohnson and Johnson
 Showing the most relevant articles for your search:NYSE:JNJ

Su Consulta Reciente

USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MRK
Merck
PM
XAUUSD
Gold vs US Dollar
AMEX
XLV
Health Care Select Sector
FX
USDMXN
US Dollar vs MXN
NYSE
CVX
Chevron
NASDAQ
AMZN
Amazon.com
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
SPI
SP500
S&P 500
NASDAQ
NVDA
NVIDIA
AMEX
SPY
SPDR S&P 500
NYSE
BAC
Bank of America
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados